Chapters and reviews

Li A, Jacks T. 2017. Driving Rel-iant Tregs toward an Identity Crisis. Immunity: 47(3):391-393. doi: 10.1016/j.immuni.2017.08.014.
Dayton TL, Jacks T, Vander Heiden MG. PKM2, cancer metabolism and the road ahead. EMBO Rep. 2016 Dec;17(12):1721-1730. Epub 2016 Nov 17. Review. PMID:27856534
Singer DS, Jacks T, Jaffee E. 2016.. A U.S. "Cancer Moonshot" to acclerate cancer research. Science: 353(6304):1105-6. doi: 10.1126/science.aai7862.
Sharp P, Jacks T, Hockfield S 2015.. Biomedical Engineering. Capitalizing on convergence for health care. Science: 352(6293):1522-3. doi: 10.1126/science.aag2350.
Sánchez-Rivera FJ, Jacks T 2015. Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer. Jul; 15(7):387-95. doi:10.1038/ncr3950. Epub 2015 Jun4.
Gierut JJ, Jacks TE, Haigis KM.2014. Strategies to achieve conditional gene mutation in mice. Cold Spring Harb Protoc. 2014 Apr 1;2014(4):339-49. doi: 10.1101/pdb.top069807.
DuPage M, Jacks T. 2013. Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response. Curr Opin Immunol. 2013 Apr;25(2):192-9. doi: 10.1016/j.coi.2013.02.005
Farago AF, Snyder EL, Jacks T. 2012. SnapShot: Lung cancer models. Cell, 149(1):246-246.e1.
Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG. 2012. Treating metastatic cancer with nanotechnology. Nat Rev Cancer, 12(1):39-50. doi:10.1038/nrc3180.
Wong KK, Jacks T, Dranoff G. 2010. NF-kappaB fans the flames of lung carcinogenesis. Cancer Prev Res (Phila). 3(4):403-5.
Ventura A and Jacks T. 2009. MicroRNAs and cancer: short RNAs go a long way. Cell, 136(4), 586-591. PMC in progress
Coussens LM, Jacks T. 2008. Genetic and cellular mechanisms of oncogenesis. Curr Opin Genet Dev;18(1):1-2. ePub.
Jacks T.2007. Modeling Cancer in the mouse. Harvey Lect. 2005-2006;101:1-19.
Jacks T.2006. The beginning of the end of frustration. Cold Spring Harb Symp Quant Biol. 2005;70:525-8.
Sandy P, Ventura A, Jacks T 2005. Mammalian RNAi: a practical guide. Biotechniques. 2005 Aug;39(2):215-24.
Shaw AT, Kirsch DG, Jacks T 2005. Future of early detection of lung cancer: the role of mouse models. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):4999s-5003s
Kim CF, Jackson EL, Kirsch DG, Grimm J, Shaw AT, Lane K, Kissil J, Olive KP, Sweet-Cordero A, Weissleder R, Jacks T..2006. Mouse models of human non-small-cell lung cancer: raising the bar. Cold Spring Harb Symp Quant Biol. 2005;70:241-50.
Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, Fraire AE, Gabrielson EW, Gunning WT, Haines DC, Kaufman MH, Linnoila RI, Maronpot RR, Rabson AS, Reddick RL, Rehm S, Rozengurt N, Schuller HM, Shmidt EN, Travis WD, Ward JM, Jacks T. 2004. Classification of proliferative pulmonary lesions of the mouse: recommednations of the mouse models of human cancers consortium. Cancer Res. 2004 Apr 1;64(7):2307-16.
Minna JD, Kurie JM, Jacks T. 2003. A big step in the study of small cell lung cancer. Cancer Cell. 2003 Sep;4(3):163-6.
McLaughlin ME, Jacks T. 2003. Neurofibromatosis type 1. Methods Mol Biol;222:223-37.
McLaughlin ME, Jacks T. 2003. Progesterone receptor expression in neurofibromas. Cancer Res. Feb 15;63(4):752-5.
Jacks T, Weinberg RA.2002. Taking the study of cancer cell survival to a new dimension. Cell. Dec 27;111(7):923-5.
Van Dyke T, Jacks T. 2002.Cancer modeling in the modern era. Progress and challenges. Cell. 108(2):135-44.
Tuveson DA, Jacks T. 2002. Technologically advanced cancer modeling in mice. Curr Opin Genet Dev. 12(1):105-10.
Reilly KM, Jacks T.2001. Genetically engineered mouse models of astrocytoma: GEMs in the rough? Semin Cancer Biol. Jun;11(3):177-91.
DePinho RA, Jacks T.2001. Introduction. The laboratory mouse in cancer research. Semin Cancer Biol. Jun;11(3):175-6.
Cichowski K, Jacks T. 2001. NF1 tumor suppressor gene function: narrowing the GAP. Cell. Feb 23;104(4):593-604.
Lim DJ, Rubenstein AE, Evans DG, Jacks T, Seizinger BG, Baser ME, Beebe D, Brackmann DE, Chiocca EA, Fehon RG, Giovannini M, Glazer R, Gusella JF, Gutmann DH, Korf B, Lieberman F, Martuza R, McClatchey AI, Parry DM, Pulst SM, Ramesh V, Ramsey WJ, Ratner N, Rutkowski JL, Ruttledge M, Weinstein DE. 2000. Advances in neurofibromatosis 2 (NF2): a workshop report. J Neurogenet. Jun;14(2):63-106.
Deshaies RJ, Jacks T.1999. Cell multiplication. Peering in and peering out: regulation of and by the cell cycle. Curr Opin Cell Biol. Dec;11(6):705-7.
Lipinski MM, Jacks T. 1999. The retinoblastoma gene family in differentiation and development. Oncogene. Dec 20;18(55):7873-82.
DePinho RA, Jacks T. 1999. A bumper crop of cancer genes. Nat Genet. Nov;23(3):253-4.
Tuveson DA, Jacks T. 1999. Modeling human lung cancer in mice: similarities and shortcomings. Oncogene.18(38):5318-24.
de Lange T, Jacks T. 1999. For better or worse? Telomerase inhibition and cancer. Cell. Aug 6;98(3):273-5.
Attardi LD, Jacks T. 1999. The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci. Jan;55(1):48-63.
Macleod KF, Jacks T. 1999. Insights into cancer from transgenic mouse models. J Pathol. Jan;187(1):43-60.
McClatchey AI, Jacks T. 1998. Tumor suppressor mutations in mice: the next generation. Curr Opin Genet Dev. 8(3):304-10. Review.
Mulligan G, Jacks T. 1998. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. Jun;14(6):223-9.
Jacks T, Weinberg RA. 1998. The expanding role of cell cycle regulators. Science. May 15;280(5366):1035-6.
Cichowski K. Jacks T. 1998. Animal models of neurofibromatosis type 1. In Neurofibromatosis Type 1, From Genotype to Phenotype, Vol 12. Oxford: BIOS Scientific Publishers Limited, pp 191-201.
Macleod K, Jacks T. 1997. The retinoblastoma gene and the control of apoptosis. In Apoptosis and Cancer, Vol 8. London: Macmillan, pp 141-64.
Brugarolas J, Jacks T. 1997. Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair. Nat Med. Jul;3(7):721-2.
Collins K, Jacks T, Pavletich NP. 1997. The cell cycle and cancer. Proc Natl Acad Sci U S A. Apr 1;94(7):2776-8.
Cichowski K, Shih TS, Jacks T. 1996. Nf1 gene targeting: toward models and mechanisms. Semin Cancer Biol. 7(5):291-8. Review.
Jacks T. 1996. Tumor suppressor gene mutations in mice. Annu Rev Genet. 30:603-36.
Jacks T. 1996. Lessons from the p53 mutant mouse. J Cancer Res Clin Oncol. 122(6):319-27.
Jacks T, Weinberg RA. 1996. Cell-cycle control and its watchman. Nature. Jun 20;381(6584):643-4.
Williams BO, Jacks T. 1996. Mechanisms of carcinogenesis and the mutant mouse. Curr Opin Genet Dev. Feb;6(1):65-70.
Cory S, Strasser A, Jacks T, Corcoran LM, Metz T, Harris AW, Adams JM. 1994. Enhanced cell survival and tumorigenesis. Cold Spring Harb Symp Quant Biol. 59:365-75.
Williams BO, Morgenbesser SD, DePinho RA, Jacks T. 1994. Tumorigenic and developmental effects of combined germ-line mutations in Rb and p53. Cold Spring Harb Symp Quant Biol. 59:449-57.
Symonds H, Krall L, Remington L, Saenz Robles M, Jacks T, Van Dyke T. 1994. p53-dependent apoptosis in vivo: impact of p53 inactivation on tumorigenesis. Cold Spring Harb Symp Quant Biol. 59:247-57.
Lowe SW, Bodis S, Bardeesy N, McClatchey A, Remington L, Ruley HE, Fisher DE, Jacks T, Pelletier J, Housman DE. 1994. Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harb Symp Quant Biol. 59:419-26.
Riccardi VM, Womack JE, Jacks T. 1994. Neurofibromatosis and related tumors. Natural occurrence and animal models. Am J Pathol. 145(5):994-1000. Review.
Hatakeyama M, Herrera RA, Makela T, Dowdy SF, Jacks T, Weinberg RA. 1994. The cancer cell and the cell cycle clock. Cold Spring Harb Symp Quant Biol. 59:1-10.
Jacks T. 1990. Translational suppression in gene expression in retroviruses and retrotransposons. Curr Top Microbiol Immunol. 157:93-124. Review.
Madhani H, Jacks T, Varmus HE. 1998. Signals for the expression of the HIV pol gene by ribosomal frameshifting. In The Control of Human Retrovirus Gene Expression. New York: Cold Spring Harbor Press, pp 119-25.